Micronized Progesterone vs Gonadotropin-releasing Hormone (GnRH) Antagonist in Freeze-all IVF Cycles.

• Status: Recruiting
• Trial end date: 2022-01-01
• Target enrollment: 0
• Participant gender: Female

Summary

To examine whether the number of euploid embryos following ovarian stimulation with micronized progesterone is equivalent as compared with the number of embryos after ovarian stimulation with the use of a GnRH antagonist in patients undergoing ovarian stimulation for IVF or intracytoplasmatic sperm injection (ICSI).

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Institut Universitari Dexeus
• Treatments: Cetrorelix; Ganirelix; Hormones; Progesterone

Criteria

Inclusion Criteria:

• Infertile patients

• Age 36-40 years old

• BMI 18-30 kg/m2

• Undergoing preimplantation genetic screening cycles

• Planned to undergo at least two treatment cycles, to accumulate embryos to increase the chance of obtaining euploid embryos for transfer

• Willing to participate in the study

Exclusion Criteria:

• Age> 41

• Severe male factor requiring TESE (testicular sperm extraction)

• Low ovarian reserve (AMH < 1.2 ng/ml)

• Administration of any other drug potentially interfering with the treatment.